跳至主要内容
临床试验/NCT02894606
NCT02894606已完成不适用

Influence of Thymoglobuline on Phenotypic and Functional Profiles of B Lymphocytes in Renal Transplant Recipients

University Hospital, Brest4 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2015年2月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
49
试验地点
4
主要终点
The distribution of mature blood B cells subpopulations will be compared between the 2 groups

研究概览

简要总结

The investigators expect to better characterise B cell subpopulation and functional properties early after graft, to analyse effect of induction therapy (thymoglobulin versus basiliximab) on B cells, and to compare this B cell profiles with those obtained in our previous study in patients with chronic Antibody Mediated Rejection (cAMR)

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age >18 years old
  • Recipient of a renal allograft
  • Patient receiving either basiliximab or thymoglobulin as in induction therapy for renal transplant
  • Patient presenting a low immunologic risk
  • Patient not opposed to his (her) study participation

排除标准

  • Patient participating in a clinical trial

研究组 & 干预措施

Thymoglobulin Induction

Patient receiving thymoglobulin as an induction therapy for renal transplant

干预措施: Thymoglobulin Induction (Drug)

Basiliximab Induction

Patient receiving basiliximab as an induction therapy for renal transplant

干预措施: Basiliximab Induction (Drug)

结局指标

主要结局

The distribution of mature blood B cells subpopulations will be compared between the 2 groups

时间窗: one year after renal transplant

Proliferation of freshly isolated cells T in presence of autologous B cells will be compared between the 2 groups.

时间窗: one year after renal transplant

次要结局

  • Serum B-cell activating factor (BAFF) concentration comparison between the two groups(one year after renal transplant)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验